Patients with 10q22.3q23.1 recurrent deletion syndrome are at risk for juvenile polyposis
François Lecoquierre(Inserm), Stéphanie Baert‐Desurmont, Y Assouline(Centre Hospitalier Universitaire de Martinique), Régine Marlin(Centre Hospitalier Universitaire de Martinique), Kévin Cassinari(Université de Pau et des Pays de l'Adour), Pascal Chambon(Université de Pau et des Pays de l'Adour), Jean–François Fléjou, Gaël Nicolas(Inserm), Odile Béra, Claude Houdayer(Inserm), Sarah Malsa(Centre Hospitalier Universitaire de Martinique), Thierry Frébourg(Inserm)
Cited by 11
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
|Immunity|2016|1.1k
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Chromosomal walking and jumping to isolate DNA from the Ace and rosy loci and the bithorax complex in Drosophila melanogaster
|Journal of Molecular Biology|1983|635